首页> BMC cardiovascular disorders> SGLT2-inhibition and myocardial infarction size in patients with type 2 diabetes mellitus- Insights from an acute cardiovascular care center.

SGLT2-inhibition and myocardial infarction size in patients with type 2 diabetes mellitus- Insights from an acute cardiovascular care center.

导出 OA

翻译打印收藏纠错

第一作者： Istvan,Bojti

第一单位： Department of Cardiology and Angiology, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, Freiburg, 79106, Germany. Istvan.bojti@uniklinik-freiburg.de.

作者： Istvan,Bojti ^[1] ; Felicitas,Bojti ^[2] ; Tau,Hartikainen ^[2] ; Philipp,Breibart ^[2] ; Nikolaus,Löffelhardt ^[2] ; Christian,Valina ^[2] ; Kilian,Franke ^[2] ; Klaus,Kaier ^[3] ; Dennis,Wolf ^[2] ; Dirk,Westermann ^[2] ; Christoph B,Olivier ^[2]

作者单位： Department of Cardiology and Angiology, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, Freiburg, 79106, Germany. Istvan.bojti@uniklinik-freiburg.de. ^[1] Department of Cardiology and Angiology, University Heart Center Freiburg - Bad Krozingen, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, Freiburg, 79106, Germany. ^[2] Institute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany. ^[3]

关键词 Acute myocardial infarction Diabetes mellitus.Infarct size SGLT2-inhibitors